Scientists have identified never-before-seen cells in the human eye that could potentially help reverse vision loss caused by common diseases, such as macular degeneration. The researchers discovered ...

Tinlarebant is a novel oral therapy designed to reduce the build-up of bisretinoids, vitamin A-based toxins that lead to retinal complications in STGD1.

Retinitis is an eye condition where the tissue at the back of the eyeball becomes inflamed. It can lead to reduced vision and vision loss. The tissue at the back of the eye is known as the retina. It ...

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...